FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizurescaused by a novel mutation

Citation
Ad. Sperfeld et al., FTDP-17: An early-onset phenotype with parkinsonism and epileptic seizurescaused by a novel mutation, ANN NEUROL, 46(5), 1999, pp. 708-715
Citations number
25
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ANNALS OF NEUROLOGY
ISSN journal
03645134 → ACNP
Volume
46
Issue
5
Year of publication
1999
Pages
708 - 715
Database
ISI
SICI code
0364-5134(199911)46:5<708:FAEPWP>2.0.ZU;2-W
Abstract
Recently, mutations in the tau gene on chromosome 17 were found causative f or autosomal dominantly inherited frontotemporal dementia and parkinsonism (FTDP-17). We describe a family carrying a missense mutation at nucleotide 1137 C --> T, resulting in the amino acid substitution P301S. Methods of in vestigations include clinical, electrophysiological, and imaging techniques . This kindred presents with a novel phenotype characterized by an early on set of rapidly progressive frontotemporal dementia and parkinsonism in comb ination with epileptic seizures. We define the dopaminergic deficits as bei ng predominantly presynaptic by the use of single-photon emission computed tomography with a dopamine transporter ligand. The association of this earl y-onset phenotype with P301S mutation is not entirely consistent with curre nt criteria for the diagnosis of frontotemporal dementias and may encourage the search for tau mutations in diseases similar but not identical to FTDP -17. Also, the change from proline to serine suggests that this mutation mi ght contribute to tau hyperphosphorylation.